Idioma:

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Dawson, Sarah-Jane ; Tsui, Dana W.Y ; Murtaza, Muhammed ; Biggs, Heather ; Rueda, Oscar M ; Chin, Suet-Feung ; Dunning, Mark J ; Gale, Davina ; Forshew, Tim ; Mahler-Araujo, Betania ; Rajan, Sabrina ; Humphray, Sean ; Becq, Jennifer ; Halsall, David ; Wallis, Matthew ; Bentley, David ; Caldas, Carlos ; Rosenfeld, Nitzan

The New England journal of medicine, 2013-03, Vol.368 (13), p.1199-1209 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Autor: Dawson, Sarah-Jane ; Tsui, Dana W.Y ; Murtaza, Muhammed ; Biggs, Heather ; Rueda, Oscar M ; Chin, Suet-Feung ; Dunning, Mark J ; Gale, Davina ; Forshew, Tim ; Mahler-Araujo, Betania ; Rajan, Sabrina ; Humphray, Sean ; Becq, Jennifer ; Halsall, David ; Wallis, Matthew ; Bentley, David ; Caldas, Carlos ; Rosenfeld, Nitzan
Assuntos: Biological and medical sciences ; Biomarkers ; Biomarkers, Tumor - blood ; Breast cancer ; Breast Neoplasms - blood ; Breast Neoplasms - genetics ; Breast Neoplasms - secondary ; Care and treatment ; Deoxyribonucleic acid ; Diagnosis ; DNA ; DNA, Neoplasm - blood ; Female ; General aspects ; Genome-Wide Association Study ; Genomes ; Gynecology. Andrology. Obstetrics ; Health aspects ; Humans ; Mammary gland diseases ; Medical imaging ; Medical sciences ; Metastases ; Mucin-1 - blood ; Mutation ; Neoplasm Metastasis - diagnosis ; Neoplasm Metastasis - diagnostic imaging ; Neoplasm Metastasis - genetics ; Prognosis ; Radiography ; Sensitivity and Specificity ; Sequence Analysis, DNA - methods ; Tumor Burden ; Tumor cells ; Tumor markers ; Tumors
É parte de: The New England journal of medicine, 2013-03, Vol.368 (13), p.1199-1209
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Descrição: This study evaluated the sensitivity of assaying tumor DNA circulating in the plasma to monitor breast cancer. This assay is compared with three other approaches: radiographic imaging, assay of cancer antigen 15-3 (CA 15-3) levels, and assay of circulating tumor cells. Breast cancer is the most common cancer and the leading cause of cancer-related death in women worldwide. 1 Metastatic breast cancer remains an incurable disease but is treatable by means of serial administration of endocrine, cytotoxic, or biologic therapies. The monitoring of treatment response is essential to avoid continuing ineffective therapies, to prevent unnecessary side effects, and to determine the benefit of new therapeutics. Treatment response is generally assessed with the use of serial imaging, but radiographic measurements often fail to detect changes in tumor burden. Therefore, there is an urgent need for biomarkers that measure tumor burden with high sensitivity . . .
Editor: Waltham, MA: Massachusetts Medical Society
Idioma: Inglês

Links

Voltar para lista de resultados

Anterior Resultado 8 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Waltham, MA: Massachusetts Medical Society

Buscando em bases de dados remotas. Favor aguardar.